- Home
- CSTL vs MRVI Comparison
CSTL vs MRVI Comparison
Compare CSTL & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- MRVI
- Stock Information
- Founded
- CSTL 2007
- MRVI 2020
- Country
- CSTL United States
- MRVI United States
- Employees
- CSTL N/A
- MRVI N/A
- Industry
- CSTL Medical Specialities
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- CSTL Health Care
- MRVI Health Care
- Exchange
- CSTL Nasdaq
- MRVI Nasdaq
- Market Cap
- CSTL 848.1M
- MRVI 809.2M
- IPO Year
- CSTL 2019
- MRVI 2020
- Fundamental
- Price
- CSTL $27.14
- MRVI $5.45
- Analyst Decision
- CSTL Strong Buy
- MRVI Buy
- Analyst Count
- CSTL 6
- MRVI 10
- Target Price
- CSTL $39.67
- MRVI $10.28
- AVG Volume (30 Days)
- CSTL 301.1K
- MRVI 1.7M
- Earning Date
- CSTL 11-04-2024
- MRVI 02-20-2025
- Dividend Yield
- CSTL N/A
- MRVI N/A
- EPS Growth
- CSTL N/A
- MRVI N/A
- EPS
- CSTL 0.21
- MRVI N/A
- Revenue
- CSTL $311,878,000.00
- MRVI $276,920,000.00
- Revenue This Year
- CSTL $51.36
- MRVI N/A
- Revenue Next Year
- CSTL N/A
- MRVI $2.85
- P/E Ratio
- CSTL $131.77
- MRVI N/A
- Revenue Growth
- CSTL 62.43
- MRVI N/A
- 52 Week Low
- CSTL $16.97
- MRVI $4.28
- 52 Week High
- CSTL $35.84
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- CSTL 39.78
- MRVI 42.91
- Support Level
- CSTL $26.99
- MRVI $5.08
- Resistance Level
- CSTL $28.08
- MRVI $5.62
- Average True Range (ATR)
- CSTL 1.51
- MRVI 0.33
- MACD
- CSTL -0.15
- MRVI 0.02
- Stochastic Oscillator
- CSTL 22.78
- MRVI 19.61
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.